Sirona Biochem Corp Stock Toronto S.E.
Equities
SBM
CA82967M1005
Biotechnology & Medical Research
Sales 2022 | 672K 493K | Sales 2023 | 34.78K 25.52K | Capitalization | 21.44M 15.73M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.2M | Net income 2023 | -2M -1.47M | EV / Sales 2022 | 48.8 x |
Net Debt 2022 | 48.04K 35.25K | Net Debt 2023 | 1.61M 1.18M | EV / Sales 2023 | 663 x |
P/E ratio 2022 |
-8.81
x | P/E ratio 2023 |
-8.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.43% |
Managers | Title | Age | Since |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 06-10-18 |
Director of Finance/CFO | - | 09-04-28 | |
Chief Tech/Sci/R&D Officer | - | 11-03-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 06-10-18 |
Alex Marazzi
BRD | Director/Board Member | - | 06-10-18 |
Director of Finance/CFO | - | 09-04-28 |
1st Jan change | Capi. | |
---|---|---|
+23.50% | 45.01B | |
+47.19% | 40.96B | |
-5.16% | 38.62B | |
+36.37% | 32.6B | |
-7.79% | 27.49B | |
+18.06% | 27.17B | |
+47.29% | 14.61B | |
+41.91% | 12.95B | |
-1.02% | 11.36B |